Ocular Therapeutix, Inc. (OCUL)

NASDAQ: OCUL · Real-Time Price · USD

10.36

-0.46 (-4.25%)

At close: Aug 28, 2026, 4:00 PM EDT

10.45

+0.09 (0.87%)

After-hours: Aug 28, 2026, 7:30 PM EDT

Ocular Therapeutix Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,275	2,586	1,343	492	216	534
Market Cap Growth	6.14%	92.64%	173.13%	127.16%	-59.47%	-65.74%
Enterprise Value	1,756	2,319	991	464	155	413
Last Close Price	10.36	12.14	8.54	4.46	2.81	6.97

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	43.71	49.79	21.07	8.41	4.20	12.27
PB Ratio	4.37	3.95	4.26	5.39	6.12	6.07
P/TBV Ratio	4.38	3.95	4.26	5.39	6.12	6.07

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	33.73	44.63	15.54	7.94	3.01	9.50

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.15	0.12	0.24	0.92	1.82	0.67
Net Debt / Equity Ratio	-1.00	-1.01	-1.00	-1.23	-1.07	-1.19
Net Debt / EBITDA Ratio	1.68	2.48	2.01	1.42	0.50	1.39
Net Debt / FCF Ratio	2.04	3.04	2.33	1.47	0.60	1.58
Asset Turnover	0.09	0.08	0.18	0.29	0.29	0.19
Inventory Turnover	67.07	61.68	49.86	31.01	35.98	44.46
Quick Ratio	12.79	15.11	10.27	6.36	3.94	7.04
Current Ratio	13.11	15.39	10.66	6.66	4.13	7.26
Return on Equity (ROE)	-72.99%	-54.85%	-95.21%	-127.64%	-115.16%	-7.99%
Return on Assets (ROA)	-34.95%	-26.66%	-28.32%	-25.66%	-27.76%	-20.90%
Return on Capital Employed (ROCE)	-50.50%	-35.70%	-38.60%	-37.90%	-66.70%	-43.70%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-13.25%	-10.28%	-14.41%	-16.42%	-32.83%	-1.23%
FCF Yield	-11.21%	-8.39%	-10.13%	-15.53%	-29.26%	-12.50%
Buyback Yield / Dilution	-26.40%	-18.31%	-84.90%	-3.57%	-0.59%	-35.24%

SEC Filings: 10-K · 10-Q